Validation shows predictive performance of high-risk models in hepatocellular carcinoma, suggesting future treatment strategies.
The three models demonstrated strong predictive performance across a diverse cohort. The Integrated Risk model, incorporating both technical and prognostic parameters was the most sensitive for identifying patients at high risk who may benefit from escalated therapy. Future studies should incorporate these models into treatment escalation strategies for HCC.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: